Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Immunoglobulin Light-chain Amyloidosis 3Burkitt Lymphoma 3Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Smoldering Multiple Myeloma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmacytoma 1Ovarian Neoplasms 1Mastocytosis, Systemic 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Plasma Cell 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Hairy Cell 1Intraocular Lymphoma 1Hodgkin Disease 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Castration-Resistant Prostate Carcinoma 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1Ann Arbor Stage II Mantle Cell Lymphoma 1Anemia 1

Interventions

Rituximab 5Vorinostat 3Lenalidomide 3Irinotecan 3Filgrastim 3Dasatinib 3tanespimycin 2laromustine 2ixabepilone 2fludarabine phosphate 2entinostat 2belinostat 2Radiotherapy 2Paclitaxel 2Etoposide 2Cyclophosphamide 2Bortezomib 2Bevacizumab 2vandetanib 1tirbanibulin 1pyroxamide 1pomalidomide 1ontuxizumab 1obatoclax 1methoxyamine 1imetelstat 1ibrutinib 1etaracizumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Intraocular Lymphoma × auricularum × Clear all
NCT01722305 2019-07-22

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Mayo Clinic

Phase 1 Completed
29 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡